Skip to Main Content

Paper Details

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.
JTO Clin Res Rep
2
2023
Osimertinib, Pneumonitis, metastatic NSCLC, osimertinib, patient, patients, pneumonitis, pulmonary tumors, radiation pneumonitis, tumors
Author NameAffiliation
Michael XiangDavid Geffen School of Medicine, University of California los angeles
Dan RuanDavid Geffen School of Medicine, University of California los angeles
Jonathan W GoldmanDavid Geffen School of Medicine, University of California los angeles
Jonathan W GoldmanDavid Geffen School of Medicine, University of California los angeles
Amy L CummingsDavid Geffen School of Medicine, University of California los angeles
Amy L CummingsDavid Geffen School of Medicine, University of California los angeles
Aaron LisbergDavid Geffen School of Medicine, University of California los angeles
Aaron LisbergDavid Geffen School of Medicine, University of California los angeles
Edward B GaronDavid Geffen School of Medicine, University of California los angeles
Edward B GaronDavid Geffen School of Medicine, University of California los angeles
Drew MoghanakiDavid Geffen School of Medicine, University of California los angeles
  • 1 - 11

Datasets